While older age is the greatest risk factor for developing Alzheimer’s disease, a less common form of the disease, known as young-onset or early-onset Alzheimer’s, can develop in those under the age of 65. Affecting 5-6% of all people...
The presence of amyloid plaques and neurofibrillary tangles in the brain has long been considered the biological sign or biomarkers of Alzheimer’s disease. Plaques form as a result of amyloid-beta protein clumping and depositing outside of the neurons in the [View More]
Cognitive health is the ability to think, learn, and remember clearly. It is needed to carry out many everyday activities effectively. Cognitive health is just one aspect of overall brain health. Many factors contribute to cognitive health. Genetic, environmental, and [View More]
My wife Bette was diagnosed with Alzheimer’s disease in 2009. Over the years, I saw firsthand Bette’s struggles, my daughter Jordana’s struggles, in addition to my own struggles as we grappled with Bette’s worsening condition, with her loss of [View More]
Valentine’s Day is traditionally a celebration of love – an undefinable emotion of deep caring and commitment to another person, the willingness to put another above self, a union of souls, a friendship for life, and an unbreakable bond. [View More]
Traveling can be enjoyable for families impacted by dementia, but it can also bring challenges, especially during the busy holiday season. To ensure the safety, comfort, and enjoyment of everyone involved, planning is critical - and a good amount [View More]
Our thanks to Janice for sharing her moving story about caring for her mom, Gabriella. Janice captures the complexity of caregiving – the often-conflicting emotions of love and anger, patience and frustration, compassion and guilt. At the same time, [View More]
This Saturday, August 17th is National Nonprofit Day – a day to recognize the positive impact that nonprofit organizations have on our local communities here in New Jersey and across the world. In the United State alone there are [View More]
Another important step forward in the fight against Alzheimer’s disease was reached last Tuesday, with the Food and Drug Administration (FDA) approval of Kisunla™ (generic name donanemab), developed by Eli Lilly. Kisunla™ is the third FDA approved disease modifying treatment, [View More]
Alzheimer’s disease can significantly impact a person’s language ability. Caregivers may notice a decline in vocabulary, comprehension and speech production due to damage to the parts of the brain that control language. The person with Alzheimer’s disease may struggle [View More]
